Filing Details
- Accession Number:
- 0001209191-18-007406
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-02-05 16:02:09
- Reporting Period:
- 2018-02-01
- Accepted Time:
- 2018-02-05 16:02:09
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1293971 | Bluebird Bio Inc. | BLUE | Biological Products, (No Disgnostic Substances) (2836) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1343543 | D Philip Gregory | C/O Bluebird Bio, Inc. 60 Binney Street Cambridge MA 02142 | Chief Scientific Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2018-02-01 | 8,500 | $0.00 | 32,272 | No | 4 | A | Direct | |
Common Stock | Acquisiton | 2018-02-01 | 1,250 | $50.51 | 33,522 | No | 4 | M | Direct | |
Common Stock | Disposition | 2018-02-01 | 301 | $202.53 | 33,221 | No | 4 | S | Direct | |
Common Stock | Disposition | 2018-02-01 | 400 | $203.73 | 32,821 | No | 4 | S | Direct | |
Common Stock | Disposition | 2018-02-01 | 800 | $205.23 | 32,021 | No | 4 | S | Direct | |
Common Stock | Disposition | 2018-02-01 | 749 | $206.12 | 31,272 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | A | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) | Acquisiton | 2018-02-01 | 34,000 | $0.00 | 34,000 | $205.25 |
Common Stock | Stock Option (right to buy) | Disposition | 2018-02-01 | 1,250 | $0.00 | 1,250 | $50.51 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
34,000 | 2028-02-01 | No | 4 | A | Direct | |
19,500 | 2026-03-01 | No | 4 | M | Direct |
Footnotes
- Restricted stock units for common stock vest over a four-year period at a rate of 25% on 01/04/2019, 25% on 01/04/2020, 25% on 01/04/2021, and 25% on 01/04/2022.
- This sales reported in the Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person on March 17, 2017.
- The range in prices for the transaction reported on this line was $202.20 to $203.15. The average weighted price was $202.5349. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The range in prices for the transaction reported on this line was $203.25 to $204.05. The average weighted price was $203.7250. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price
- The range in prices for the transaction reported on this line was $204.80 to $205.65. The average weighted price was $205.2250. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price
- The range in prices for the transaction reported on this line was $205.85 to $206.40. The average weighted price was $206.1235. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price
- This option vests over a four-year period, at a rate of twenty-five percent (25%) on January 4, 2019, and in 36 equal monthly installments.
- This option vests over a four-year period, at a rate of twenty-five percent (25%) on January 4, 2017 and in 36 equal monthly installments thereafter.